Nextech Crossover I Scsp reports 9.9% passive shares of Context Therapeutics as of May 6th — SEC
截至5月6日Nextech Crossover I Scsp报告称Context Therapeutics的被动股份为9.9％——美国证券交易委员会
Nextech Crossover I Scsp reports 9.9% passive shares of Context Therapeutics as of May 6th — SEC
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.